Find an expert

Professor Wolvetang is an international leader in the area of pluripotent stem cell biology and human functional genomics. he initiated and leads Cell Reprogramming Australia, a collaborative framework that facilitates induced pluripotent stem cell research in Australa and is co-director of the UQ Centre in Stem Cell Ageing and Regenerative Engineering (StemCARE). He has extensive expertise in reprogramming somatic cells, differentiation and tissue engineering with adult, embryonic and induced pluripotent stem cells, genome manipulation with CRISPR, molecular biology, transcriptome analysis, high content image analysis, development and use of microfluidic devices for cell analysis, nanoparticle and scaffold design and delivery, and stem cell and cell-free regenerative medicine approaches.Professor Wolvetang has been instrumental in establishing and enabling the technology for derivation of induced pluripotent stem cells across Australia. Professor Wolvetang made the strategic decision to focus on the generation of induced pluripotent stem from patients with neurological and cardiac disorders because live human cells from such patients can usually not be obtained whereas induced pluripotent stem cells have the ability to generate every cell type of the human brain in unlimited amounts and can recapitulate the disease in the dish. Induced pluripotent stem cells combined with emerging technologies such as CRISPR-based genome editing offers a unique opportunity to study the role of individual genes and combinatorial gene regulatory pathways in the eatiology of monogenic and complex brain disorders. Indeed, combined with RNA-seq and organoid generation we are now for the first time able to gain insight into gene regulatory pathways operational in individual brain cell types of healthy and diseased individuals, investigate the connectivity and function of cells, as well as pinpoint where and when during early development such deregulated pathways lead to pathological changes. Induced pluripotent stem cells further not only provide insight into the underlying pathogenesis of neurological disorders but also constitute a valuable drugscreening platform and, following CRISPR-based gene correction, can form the basis of patient specific cellular therapies for currently incurable diseases.

Professor Wolvetang received his PhD in 1992 from the Department of Biochemistry, University of Amsterdam for his original work on peroxisomal disease (6 papers). He undertook postdoctoral studies at the Department of Biochemistry and the Institute for Reproduction and Development of Monash University, investigating apoptosis, Down syndrome and Ets transcription factors, respectively, obtaining the first evidence for an intra-chromosomal regulatory loop on chromosome 21 involving Ets2 (3 papers), and revealing the role of p53 in immune-suppression in Down syndrome (Hum Mol. Genetics). He then joined Prof Martin Pera in the Australian Stem Cell Centre in 2003 to pioneer human embryonic stem cell research in Australia, resulting in a first author Nature Biotechnology paper in 2006 identifying CD30 as a marker for genetically abnormal hESC (72 cites). He was appointed group leader of the Basic human stem cell biology laboratory in the ASCC research laboratory and senior lecturer in the Department of Anatomy and Cell biology until he accepted his current position as an independent group leader at the AIBN and Professor in stem cell biology at the University of Queensland in 2008. There he started to generate integration-free induced pluripotent stem cells from human neurological diseases such as ataxia-telangiectasia (Stem cells translational medicine). In recognition of his leadership role in this area of research he was appointed leader of the “Reprogramming and Induction of pluripotency” Collaborative Stream of the Australian Stem Cell Centre until the end of that initiative in 2011, coordinating collaborative research between eight stem cell laboratories across Australia. He subsequently initiated and is now the president of Cell Reprogramming Australia, a collaborative framework aiming to facilitate and accelerate iPS cell research in Australia and the Asia pacific region and inform the general public about reprogramming technology. His research continues to combine cell reprogramming technology, genome editing/analysis tools and microfluidic/nanoparticle based detection/ delivery technologies with the aim of creating human in vitro models of disease, unravel the underlying gene regulatory networks and enable novel cell- and delivery-based therapeutics, respectively. He further co-direct the UQ-Centre for stem cell ageing and regenerative engineering (UQ-StemCARE).

Dr Woodruff is a Professor of Pharmacology who leads a research team aiming to find new therapeutic treatments for neurodegenerative disorders. Current therapies for these diseases are vastly inadequate, and so new research is needed to identify novel targets to slow or halt their progression. Prof Woodruff’s specific research revolves around the innate immune system in the brain, and the role of neuroinflammation in propagating disease. A key focus of his current work is testing new drugs developed at the University of Queensland in models of motor neuron disease (amyotrophic lateral sclerosis), Huntington’s disease, and Parkinson's disease, as well as maintaining an active interest in acute inflammatory disorders including sepsis and ischemia-reperfusion injuries. Using a series of potent and orally active complement C5a and NLRP3 inflammasome inhibitors developed at UQ, Prof Woodruff's team has demonstrated the therapeutic potential of targeting innate immune-mediated neuroinflammation to reduce neuronal cell death in animal models of these neurodegenerative diseases. His team has recently shown that in addition to their roles in neurodegeneration, innate immune factors also play essential roles in stem and neuronal cell development during embryogenesis, revealing the widespread physiological and pathological roles of this evolutionarily ancient immune system.

Dr Lee Woods is a clinician researcher at the Queensland Digital Health Centre at The University of Queensland, Fellow of the Australasian Institute of Digital Health and practicing primary care registered nurse. Her research program focuses on safe, effective, and equitable digital transformation in healthcare. Dr Woods’ Digital Health CRC funded postdoctoral work involved the first Australian state-wide, academic-led digital maturity assessment across Queensland, spanning all 16 healthcare systems. Findings from the Queensland Health digital maturity assessments have been used by regional health services executives for local IT infrastructure business cases, have informed the refresh of Queensland Health’s Digital Health Strategy 2022 and the lessons learned have been translated internationally. Dr Woods has a national profile for her work on building the digital health capabilities of the Australian health workforce. Dr Woods is often invited to speak at national forums, teaches digital health into the clinical degrees at The University of Queensland and is engaged in academic consulting. Her previous roles in government, education sector and healthcare organisations across three states and in private, public and primary health services positions her well for clinical translation and policy reform. Her work has informed federal digital health strategy through project management of two foundational workforce and education documents at the Australian Digital Health Agency. Dr Woods was on the Project Leadership Team to develop Australia’s first national Clinical Informatics Fellowship Program, a partnership between academia and two national peak bodies. 

Mechanisms of drug-induced liver damage.

Liver disease has long been associated with the abuse and clinical use of drugs. My research interests focus on ethanol, perhaps the most commonly abused drug, and the widely used non-steroidal anti-inflammatory drugs (NSAIDS). Both NSAIDS and ethanol are widely tolerated but induce liver disease in a small number of individuals.

Research projects listed below investigate immunological and genetic phenomena associated with drug-induced liver disease.

• Does ethanol alter hepatic gene expression to cause liver damage?
• Does ethanol alter hepatocyte sensitivity to cytokines leading to cell death?
• Is protein modification by ethanol metabolites involved in the aetiology of alcoholic liver disease?
• Do keratin 8 or 18 mutants sensitise the liver to toxins?
• Is an aberrant immune response involved in NSAID adverse reactions?
• What is the mechanism of toxicity of the Bracken fern toxin ptaquiloside?

Helen has over 30 years’ experience as a clinician (orthoptist) and an innovative educator. She was the Academic Lead Assessment in the Academy for Medical Education from mid 2017 to March 2024. Helen’s expertise has been built on a career spanning clinical practice in rural and urban settings fuelling a passion for learning from her early mentor, the late Prof Fred Hollows. Her career in higher education has spanned several roles including lecturing and reforming the orthoptics curriculum, leading elearning projects across five health facilities at the University of Sydney before moving to lead academic development at Charles Darwin University. She has worked in three medical schools (University of Sydney, Flinders University and the University of Queensland) inspiring educators to enhance clinical skills teaching, developing clinical supervisors in Northern Australia and most recently leading assessment design for the new Doctor of Medicine program at University of Queensland. She has received multiple teaching and learning awards at University of Sydney (2003, 2004), Flinders University (2016) and the Australian Awards for University Teaching: Citation for Outstanding Contributions to Student Learning (2017).

Olivia is a Senior Lecturer in Nutrition and Dietetics at the School of Human Movement and Nutrition Sciences, The University of Queensland and a Senior Research Fellow with the Centre for Nutrition and Food Sciences (CNAFS), The Queensland Alliance for Agriculture and Food Innovation (QAAFI). Olivia has a strong track record in leading multidisciplinary research. Her main research streams include clinical trials examining the bioavailability of nutrients and the impact on clinical outcomes and/or gene expression; the uptake and maintenance of healthy and sustainable dietary patterns; innovative models of service delivery to prevent nutritional decline and improve quality of life for older people; service co-design, delivery, and evaluation across various areas of dietetics practice. Olivia also collaborates with industry partners to trial novel foods and ingredients.

Olivia is a highly supportive postgraduate advisor, mentoring 13 PhD students (5 to completion, 3 as primary; 8 continuing). She regularly supervises Master of Dietetics Studies coursework research students (around 22 projects 2009-2022) and supervised 2 honours students (2011).

Olivia is an Associate Editor for the international journal, Nutrition Journal, (BMC, Springer Nature). In 2010, she received Advanced Accredited Practising Dietitian status, as recognition of her professional leadership and expertise and in 2011 won the Women in Technology "Rising Star" Award. She has received significant research funding, including support from the Australian Research Council, the National Health and Medical Research Council, Queensland Health and Horticulture Innovation Australia.

Yanfei has a discipline background as a physiotherapist. She completed her PhD at The University of Queensland in October 2021. Her PhD involved ultrasound shear wave elastography, quantitative sensory testing, and physical and psychological measures to uncover potential biopsychosocial mechanisms underlying work-related neck pain and disability in a high-risk occupation group. After her PhD, she was awarded a competitive UQ postdoctoral fellowship to conduct research related to musculoskeletal pain and injury at RECOVER Injury Research Centre. Her current research focuses on uncovering the biopsychosocial mechanisms underlying musculoskeletal pain and injury, developing, and implementing effective and tailored pain treatments. She also has interests in occupational health and health equity. She has a broad range of research skills applicable across methodologies, including randomized controlled trials, case-control, and longitudinal study designs, systematic and scoping reviews, and meta-analysis. Yanfei has presented her work at national and international conferences and received several presentation awards.

Dr. Ayaho Yamamoto is the Group Leader of Laboratory Science at the Children's Health and Environmental Program and is a research fellow in the field of Biomedical Science. Her research focuses on understanding the mechanistic links between environmental exposures and adverse respiratory outcomes. In particular, she focuses on the cellular responses following air pollution exposure and/or viral infection on human respiratory epithelium, and the age differences in immune defence mechanisms. Investigate on early intervention strategies with dietary antioxidants to improve respiratory health and reduce the risk of long-term chronic diseases.

Dr. Yamamoto has a Bachelor of Science in Environmental Health and Public Health; her research focused on childhood asthma. She has a Master of Science in Biomedical Science and Pharmacology; the research focus was to understand the mechanisms and to test new drugs for osteoporosis and chondrosarcomas metastasis. She has worked in a Uni-based start-up company for drug development.

Professor Ian Yang is a Thoracic Physician and Director of Thoracic Medicine at The Prince Charles Hospital, and Head of the PCH-Northside Clinical Unit, School of Clinical Medicine, Faculty of Medicine, The University of Queensland, Brisbane, Australia.

My group studies the role of cadherin cell adhesion molecules in morphogenesis and tumor development. E-cadherin is a key mediator of cell-cell recognition. It participates in tissue patterning and its dysfunction contributes to tumor progression and invasion.

Associate Professor Yap is the group leader for Cadherin cell adhesion molecules, Epithelial morphogenesis & Cell locomotion research at the IMB.

A clinical psychologist trained in psychoanalytic psychotherapy with many years of clinical experience, with interest in the understanding of psychosomatic relationships as they appear in clinical practice, and with interest in the understanding of the therapeutic relationship as instance of change, particularly in the treatment of children and young people. This translates into an interest in researching the psychotherapy process with a tendency toward the use of qualitative or mixed methods.

I am an Advanced Accredited Practicing Dietitian (AdvAPD), and currently hold positions at the Royal Brisbane and Women’s Hospital (Research Coordinator, Nutrition and Dietetics), and University of Queensland (Senior Research Fellow, Centre for Health Services Research).

My research program aims to improve nutrition care in Australian hospitals to prevent avoidable hospital-acquired complications and optimise patient outcomes, particularly for older inpatients. My research program consists of extensive observational research to establish the size and impact of the problem, qualitative research to understand patient, caregiver and staff perspectives and opportunities, and pragmatic implementation research to test, compare and evaluate different models of nutrition care in practice. Through my research, I am to improve care of people accessing health services across the continuum of care, with a particular interest in frailty, preventing delirium and functional decline, and person-centred care.

My research has been of interest nationally and internationally, receiving Research in Practice awards at national Dietitians Australia conferences, Young Achiever Award by the Dietitians Association of Australia in 2014 and New Researcher Award at the International Congress of Dietetics in 2012. My leadership and contribution to the dietetics profession was recently recognised through receiving the prestigious Barbara Chester Memorial Award.

I have an interest and developing expertise in consumer engagement in research and health service improvement, and I am regularly asked to speak on this topic at conferences, forums and panel discussions. I am proud of work I co-led with a health consumer to develop a co-design framework in Metro North Health. This framework is freely available online for anyone to use: https://metronorth.health.qld.gov.au/get-involved/co-design.

I am an implementation scientist and have facilitated workshops on this topic at UQ, QUT, University of Adelaide and Metro North HHS within a team of local and international experts. I was part of the team that developed the Allied Health Translating Research into Practice (AH-TRIP) initiative, which aims to increase knowledge translation capacity for health professionals. https://www.health.qld.gov.au/clinical-practice/database-tools/translating-research-into-practice-trip/translating-research-into-practice.

As a passionate advocate for the training and career pathways for clinician-scientists, I have supervised 3 PhDs to completion, and is currently supervising 6 research higher degree candidates (5 of whom are embedded health professionals within the health system), 4 early career research fellows and nearly 40 dietetics research honours students.

Trained as a veterinarian, Dr Yuen is a veterinary microbiologist with expertise in pathobiology, host-pathogen interactions, and immunology in infectious diseases. Currently, he is a veterinary virologist at the Elizabeth Macarthur Agricultural Institute within the NSW Department of Primary Industries and Regional Development, and holds an adjunct research fellow position at the School of Veterinary Science at UQ. While his current research focuses on vaccine development and immunology, he has active collaborations with academics in universities and research institutes in the areas of antimicrobial resistance, disease biomarkers discovery, epidemiology of emerging zoonotic diseases, and disease pathogenesis.

Dr. Norhasnida Zawawi has been an Honorary Senior Fellow at the Queensland Alliance for Agriculture and Food Innovation (QAAFI) since 2019. She has joined the Australian Native Bee Association (ANBA) subcommittee for the development of native bee honey standard application to Food Standards and Australia and New Zealand (FSANZ) since 2020. Currently based in Malaysia, she is a senior lecturer at the Department of Food Science, Faculty of Food Science and Technology (FSTM), Universiti Putra Malaysia (UPM) and a food and nutritional scientist affiliated with two laboratories, the Laboratory of Functional Carbohydrate and Protein at FSTM and Laboratory of Halal Science at the Halal Products Research Institute, both in UPM. Her administration and research responsibilities include being a member of the Working Group for Kelulut Honey (native bee honey) Standard under the Department of Standards Malaysia, Ministry of International Trade and Industry (MITI), Malaysia, and Vice President of the Task Group for Stingless Bee Honey Standard elected by Apimondia Asia. Recently, she has been appointed as an Editorial Board Member of the Pertanika Journal of Tropical Agricultural Science, one of UPM's publications and have had experiences as reviewer of scientific manuscripts in her field of research for many high-impact factor journals such as Food Research International, Current Research in Food Science, Food Bioscience and Journal of Apicultural Research. Together with QAAFI research team, she has made the discovery of a rare sugar (trehalulose) as the primary sugar available in the native bee honey during her 9 months research attachment in 2018. As the principal investigator for 7 research projects, she was awarded grants from UPM and government ministries amounting to RM906,340.00. Currently, thirty-seven of her research publications are Scopus-indexed with a total of 624 citations, earning her the H-index of 17.

Dr Yinghong Zhou leads the ImmunoEngineering for Regenerative Dentistry research team at the School of Dentistry. Her research interests extend across several transdisciplinary research projects, all with the central theme of biomedical engineering and bone/periodontal tissue regeneration. Her high-quality research leads the field in (a) hypoxia-mimicking bioscaffolds for bone regeneration (field-weighted citation impact=13.15), (b) trace element-mediated biomineralization (recognised by the Tissue Engineering and Regenerative Medicine International Society (TERMIS) Young Investigator Award, given only to two emerging researchers in the whole Asia-Pacific region in 2021), and (c) immunoengineering approaches for periodontal regeneration (introduced into the tertiary learning sector as the world-first Master of Philosophy (Materiobiology) Program at QUT). Dr Zhou has been awarded prestigious fellowships including the Endeavour Research Fellowship (2017), NHMRC Early Career Fellowship (2016-2020), and the BridgeTech Industry Fellowship (2021).

Dr Zyta Ziora received PhD (Wroclaw University of Science & Technology, Poland) in chemistry and has wide range of experience in development of antimalarial therapeutics (the University of Montpellier, France), antibacterial agents, enzyme inhibitors and drug candidates against Alzheimer disease (Kyoto Pharmaceutical University, Japan). Her research time is currently dedicated mainly to projects devoted to the modification of existing antibiotics, and complexing them with additional antimicrobial agents, like metal ions, to produce more potent alternatives and by this to overcome the drug resistance of superbugs. She is also working on alternative to antibiotics nature-derived compounds with antimicrobial and anticancer potency, such poliphenolic derivatives to control tyrosinase function.

Rebeka R. Zsoldos is an animal biomechanist who graduated at the Animal Science Faculty of the University of Kaposvar/Hungary (2008). In Vienna/Austria, she then completed her PhD on the biomechanics of the equine cervical vertebral column at the Movement Science Group at the Veterinary University (2011), followed by her own collaborative research project titled “Generic Motion Models based on Quadrupedal Data” at the University of Natural Resources together with the Veterinary University and the University of Bonn/Germany (Multimedia, Simulation and Virtual Reality Group). During this time, she taught Animal Biomechanics to undergraduate and graduate students. Having completed the project, she continued work with her collaborators at the University of Bonn in Germany. After that she worked on a mathematical approach to the elastic behaviour and shape of the equine spine as a postdoctoral research fellow at the Computational Sciences Group, King Abdullah University of Science and Technology (KAUST) in Thuwal in the Kingdom of Saudi Arabia.